asopharyngeal pneumococcal colonization data in infants at the age of 12, 18 and 24 months - Pneumococcal carriage in infants

ederlands Vaccin Instituut0 个研究点开始时间: 2008年5月30日最近更新: 2017年10月2日

试验速览

暂无简介。

•These criteria are derived from the related MINOES study, in order to increase comparability
•The children have to be of normal health (same health criteria apply as used in well-baby clinics when a child receives a vaccination, e.g. also children with small increases in temperature or cold are seen as children with normal health)
•They have to be willing and able to participate in the trial according to procedure
•Presence of a signed informed consent (the parents/legally representatives have
•given written informed consent after receiving oral and written information)
•The children have received the Prevenar® vaccinations according to the 3+1 schedule of the Dutch NIP
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•These criteria are derived from the related MINOES study, in order to increase comparability
•Previous vaccinations with Prevenar® using a schedule that differs from the Dutch 3+1 schedule
•Previous vaccinations with other pneumoccocal vaccines
•Previous vaccinations of older brother(s) and/or sister(s) and/or parents with a pneumococcal conjugate vaccine (e.g. brother(s) and/or sister(s) that participated in the MINOES trial)

发起方

ederlands Vaccin Instituut